The existing experimental data have fully shown that inhibition of the NF-κB signal pathway can inhibit tumor proliferation and promote tumor cell apoptosis, so it is a hot spot in tumor medicine to develop inhibitors for tumor therapy. The gene discussed is NFKB1; the disease is neoplasm.